78 results
Page 4 of 4
8-K
EX-99.1
ptdpeqk9yx2csf
25 May 21
Longeveron Announces the Appointment of Ursula Ungaro to its Board of Directors
10:15am
10-Q
y3s0m0gh vr
14 May 21
Quarterly report
4:08pm
8-K
EX-99.1
mydx6 pyv
14 May 21
Results of Operations and Financial Condition
8:54am
8-K
EX-99.1
adpp9 tdncc8s
11 May 21
Regulation FD Disclosure
11:42am
8-K
EX-99.1
gvvxif aia18yz
15 Apr 21
Regulation FD Disclosure
9:08am
8-K
EX-99.1
8zye77e2sv5wph
13 Apr 21
Longeveron Announces Positive Results of Phase I Clinical Study of Lomecel-B Cell Therapy for Alzheimer’s Disease
9:18am
10-K
n1r06o4
30 Mar 21
Annual report
4:51pm
8-K
EX-99.1
2jxc5
30 Mar 21
Longeveron Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
9:03am
8-K
EX-99.1
uvnzf
15 Mar 21
Longeveron Inc. Announces Partial Exercise of Over-Allotment Option in Initial Public Offering
4:30pm
8-K
EX-99.1
d4mo6mxj1mudx
9 Mar 21
Longeveron and University of Miami Expand Exclusive License Agreement, and Enter into CRADA To Facilitate Future Collaborations
4:21pm
424B4
k1shi2m9zo86y3d785
12 Feb 21
Prospectus supplement with pricing info
4:09pm
FWP
imh0arxt 23
3 Feb 21
Free writing prospectus
5:01pm
S-1/A
kalmu5vwmoif i9bz6c
3 Feb 21
IPO registration (amended)
4:57pm
S-1
gikq70aogljqqdu
19 Jan 21
IPO registration
5:21pm
DRS/A
2frw6v9ux sg
30 Dec 20
Draft registration statement (amended)
12:00am
DRS
q6hxppe2
12 Nov 20
Draft registration statement
12:00am